Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Cash & Equivalents Over TimeStrong
Percentile Rank86
3Y CAGR+12.9%
5Y CAGR+5.6%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+12.9%/yr
vs +16.9%/yr prior
5Y CAGR
+5.6%/yr
Recent acceleration
Acceleration
-4.0pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$214.01M+0.1%
2024$213.75M-13.5%
2023$246.99M+66.0%
2022$148.81M-39.3%
2021$245.20M+50.2%
2020$163.24M+14.3%
2019$142.84M+79.1%
2018$79.75M+62.6%
2017$49.06M-73.8%
2016$187.03M-